Randomized Study of Obicetrapib in Combination With Ezetimibe
Conditions: Dyslipidemias; High Cholesterol; Hypercholesterolemia Interventions: Drug: Obicetrapib 5mg; Drug: Ezetimibe 10mg; Other: Placebo Sponsor: NewAmsterdam Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials